Clinical Trial Update: Epetraborole in Patients With Mycobacterium Abscessus Lung Disease [Phase 2]

View source ↗

Summary

Epetraborole is being studied in a Phase 2 trial for Mycobacterium abscessus infection, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Infection

Drugs mentioned

• Epetraborole (epetraborole)

Snippet

Sponsor: Kevin Winthrop | Conditions: Mycobacterium Abscessus Infection | Phase 2 | Status: NOT_YET_RECRUITING